|ECR 2013 / C-0702|
|MSCT in GIST patients with hepatic metastases treated with new generation tyrosinkinase inhibitors: comparison between density and dimension.|
2 patients (33%) showed a partial response, with a dimensional and densitometric lesions reduction. 3 patients (50%) showed stable disease with diameters unchanged although it was a reduction of the lesions density. Only 1 patient (17%) did not respond to therapy, showing after 6 months disease progression with an increase of lesions number.
Overall, after 3 and 6 months of treatment we have observed a reduction of the liver lesions total diameter average by 8% and 10% respectively, and a reduction lesions density average by 20% and 26% respectively.
Thematically related posters
ECR 2013 / C-2528
CT findings, clinicopathologic features and treatment modalities of anorectal melanoma: analysis of 10 cases
ECR 2013 / C-0906
The measurement of metastatic lesions in post therapy liver: intra- and inter- observer variability